Fonar Corporation  

(Public, NASDAQ:FONR)   Watch this stock  
Find more results for FONR
+0.01 (0.05%)
Jan 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 10.16 - 10.36
52 week 9.32 - 25.75
Open 10.24
Vol / Avg. 0.00/37,755.00
Mkt cap 65.40M
P/E 6.42
Div/yield     -
EPS 1.58
Shares 6.05M
Beta 1.51
Inst. own 18%
Nov 10, 2014
Q1 2015 Fonar Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2014
Net profit margin 18.10% 19.56%
Operating margin 19.12% 17.98%
EBITD margin - 23.53%
Return on average assets 16.79% 17.87%
Return on average equity 35.68% 49.31%
Employees 430 -
CDP Score - -


110 Marcus Dr
MELVILLE, NY 11747-4228
United States - Map
+1-631-6942929 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Fonar Corporation (Fonar) operates in two segments: medical equipment segment, and physician management and diagnostic services segment. The Company is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. Health Management Corporation of America (HMCA) was established as a wholly owned subsidiary to enable the Company to expand into the business of providing management services to medical providers. HMCA provides management services, administrative services, billing and collection services, office space, equipment, repair, maintenance service and clerical and other non-medical personnel to medical providers. As of June 30, 2012, Imperial managed 11 diagnostic imaging facilities located in states of New York and Florida.

Officers and directors

Raymond V. Damadian M.D. Chairman of the Board, President, Treasurer
Age: 77
Bio & Compensation  - Reuters
Claudette J. V. Chan Secretary, Director
Age: 75
Bio & Compensation  - Reuters
Charles N. O'Data Lead Independent Director
Age: 77
Bio & Compensation  - Reuters
Robert J. Janoff Independent Director
Age: 86
Bio & Compensation  - Reuters
Ronald G. Lehman Independent Director
Age: 37
Bio & Compensation  - Reuters